Notfälle
Blutspende
Karriere
Presse
Forschung
Lehre
Patienten
Zuweiser

Andersson E, Villabona L, Bergfeldt K, Carlson J, Ferrone S, Kiessling R, Seliger B, Masucci G. Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancer. Cancer Immunol Immunother. 2012; 61:1243-53.

 

Buettner M, Xu H, Böhme R, Seliger B, Jacobi J, Wiesener M, Benz K, Amann K. Predominance of Th2 cells and plasma cells in polyoma virus nephropathy: a role for humoral immunity? Hum Pathol. 2012; 43:1453-62.

 

Lichtenfels R, Rappl G, Hombach A, Recktenwald C, Dressler S, Abken H, Seliger B. A proteomic view at T cell costimulation. PLoS One. 2012; 7:e32994.

 

Stölzel F, Hackmann K, Kuithan F, Mohr B, Thiede C, Röllig C, Platzbecker U, Schetelig J, Schaich M, Seliger B, Hartmann A, Baretton G, Zietz C, Ehninger G, Schrock E, Bornhäuser M. Clonal evolution including partial loss of MHC-I genes favoring extramedullary AML relapse after allogeneic HSCT. Transplantation. 2012; 93:744-9.

 

Okita R, Mougiakakos D, Ando T, Mao Y, Sarhan D, Wennerberg E, Seliger B, Lundqvist A, Mimura K, Kiessling R. HER2/HER3 signaling regulates NK cell-mediated cytotoxicity via MHC class I chain-related molecule A and B (MICA and MICB) expression in human breast cancer cell lines. J Immunol. 2012; 188:2136-45.

 

Wulfänger J, Schneider H, Wild P, Ikenberg K, Rodolfo M, Rivoltini L, Meyer S, Riemann D, Seliger B. Promoter methylation of aminopeptidase N (APN)/CD13 in malignant melanoma. Carcinogenesis. 2012; 33:781-90.

 

Bukur J, Jasinski S, Seliger B. The role of classical and non-classical HLA class I antigens in human tumors. Semin Cancer Biol. 2012; 22:350-8.

 

Seliger B, Hesse A, Wild PJ, Ikenberg K, Meyer S, Wulfänger J, Willimsky G, Pawelec G, Lichtenfels R. Expression and function of the myelin fatty acid binding protein in melanoma cells. Journal of Translational Medicine. Under revision. 

 

Tudor C, Dawson C, Eckhardt J, Niedobitek G, Buettner A, Seliger B, Hartmann A, Buettner M. C-Myc serves to counteract LMP1 regulation of the HLA class I antigen presentation machinery in nasopharyngeal carcinoma. Br J Cancer. 2012; 106:1980-8.

 

Recktenwald C, Leisz S, Steven A, Mimura K, Müller A, Wulfaenger J, Kiessling R, Seliger B. HER-2/neu-mediated downregulation of biglycan associated with altered growth properties. J Biol Chem. 2012; 287:24320-9.

 

Kiessling R, Okita R, Mougiakakos D,  Mao Y, Sarhan D, Wennerberg E, Seliger B, Lundqvist A, Mimura K, Kono K. Opposing consequences of signaling through EGF family members; escape from CTLs could be a bait for NK cells. OncoImmunology. Accepted.

 

Seliger B, Quandt D. The expression, function, and clinical relevance of B7 family members in cancer. Cancer Immunol Immunother. 2012; 61:1327-41.

 

Buettner M, Xu H, Böhme R, Seliger B, Jacobi J, Wiesener M, Benz K, Amann K. Predominance of Th2 cells and plasma cells in polyoma virus nephropathy: a role for humoral immunity? Hum Pathol. 2012; 43:1453-62.

 

Breuer D, Unverzagt S, Altermann W, Schlaf G, Seliger B. Multiplex analysis of urinary markers for monitoring kidney transplant rejection. Proteomics. Under revision

 

Horsch M, Geissler S, Mueller H, Hrabe de Angelis M, Seliger B, Beckers J. Dynamic gene expression changes following transcriptional repression of Erbb2 in mouse and human cancer cell lines. Mol Cell Cancer. Under revision. 2011.

 

Lichtenfels R, Mougiakakos D, Johansson CR, Dressler S, Recktenwald CV, Kiessling R, Seliger B. Comparative expression profiling of distinct T subsets undergoing oxidative stress. PLoS One. 2012; 7(7):e41345.